New Classics Media

Insect Cell Culture Market Size to Grow USD 3.74 Billion by 2029 at a CAGR of 8.3% | Valuates Reports

Retrieved on: 
Thursday, November 30, 2023

The global Insect Cell Culture market was valued at USD 2.31 Billion in 2022 and is anticipated to reach USD 3.74 Billion by 2029, witnessing a CAGR of 8.3% during the forecast period 2023-2029.

Key Points: 
  • The global Insect Cell Culture market was valued at USD 2.31 Billion in 2022 and is anticipated to reach USD 3.74 Billion by 2029, witnessing a CAGR of 8.3% during the forecast period 2023-2029.
  • Claim Your Free Sample Now: https://reports.valuates.com/request/sample/QYRE-Auto-35F1907/Global_Ins...
    Major Factors Driving the Growth of Insect Cell Culture Market:
    The market for insect cell culture is expanding significantly due to its many uses in biotechnology.
  • The market for insect cell culture is developing due to its growing use in the manufacturing of vaccines.
  • The market for insect cell culture is expanding as a result of increased expenditures made in the biotechnology industry worldwide.

Insect Cell Culture Market Size to Grow USD 3.74 Billion by 2029 at a CAGR of 8.3% | Valuates Reports

Retrieved on: 
Thursday, November 30, 2023

The global Insect Cell Culture market was valued at USD 2.31 Billion in 2022 and is anticipated to reach USD 3.74 Billion by 2029, witnessing a CAGR of 8.3% during the forecast period 2023-2029.

Key Points: 
  • The global Insect Cell Culture market was valued at USD 2.31 Billion in 2022 and is anticipated to reach USD 3.74 Billion by 2029, witnessing a CAGR of 8.3% during the forecast period 2023-2029.
  • Claim Your Free Sample Now: https://reports.valuates.com/request/sample/QYRE-Auto-35F1907/Global_Ins...
    Major Factors Driving the Growth of Insect Cell Culture Market:
    The market for insect cell culture is expanding significantly due to its many uses in biotechnology.
  • The market for insect cell culture is developing due to its growing use in the manufacturing of vaccines.
  • The market for insect cell culture is expanding as a result of increased expenditures made in the biotechnology industry worldwide.

China Literature Announces 2023 Interim Results

Retrieved on: 
Thursday, August 10, 2023

HONG KONG, Aug. 10, 2023 /PRNewswire/ -- China Literature Limited ("China Literature" or "the Company", stock code: 0772), a leading online literature and intellectual property ("IP") incubation platform in China, today announced the unaudited consolidated results for the six months ended June 30, 2023.

Key Points: 
  • HONG KONG, Aug. 10, 2023 /PRNewswire/ -- China Literature Limited ("China Literature" or "the Company", stock code: 0772), a leading online literature and intellectual property ("IP") incubation platform in China, today announced the unaudited consolidated results for the six months ended June 30, 2023.
  • Mr. Hou Xiaonan, Chief Executive Officer of China Literature, commented, "In the first half of 2023, China Literature continued to prioritize quality over quantity, focus on creating enduring and high-quality IP, and improve operational efficiency.
  • We believe this new organizational structure will empower China Literature to leverage generative AI to re-shape our products and business processes.
  • We are creating a brand new China Literature to seize this once-in-a-generation opportunity, and we are confident in our long-term prospects.

China Literature Announces 2022 Annual Results

Retrieved on: 
Thursday, March 16, 2023

HONG KONG, March 16, 2023 /PRNewswire/ -- China Literature Limited ("China Literature" or "the Company", stock code: 0772), a leading online literature and intellectual property ("IP") incubation platform in China, today announced the audited consolidated results for the year ended December 31, 2022.

Key Points: 
  • HONG KONG, March 16, 2023 /PRNewswire/ -- China Literature Limited ("China Literature" or "the Company", stock code: 0772), a leading online literature and intellectual property ("IP") incubation platform in China, today announced the audited consolidated results for the year ended December 31, 2022.
  • Mr. Edward Cheng, Chief Executive Officer of China Literature, commented: "We experienced major macro changes in 2022, and witnessed efforts across the digital entertainment industry to improve content quality and ROI.
  • The other losses in 2022 mainly consisted of a net fair value loss related to certain investee companies and acquisitions.
  • These blockbusters are all enabled by the unique strengths of China Literature's proprietary IPs, its ability to mobilize resources across the entire value chain, as well as the production capabilities of New Classics Media and China Literature Pictures.